Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kenvue
Pharma
Troubled Kenvue sells itself to Kimberly-Clark in $48.7B buyout
Kimberly-Clark has placed an ambitious bet on a troubled counterpart, agreeing to buy out J&J's consumer health spinout Kenvue for $48.7 billion.
Kevin Dunleavy
Nov 3, 2025 11:51am
Texas AG sues Kenvue over alleged Tylenol-autism link
Oct 28, 2025 1:16pm
Kenvue presses FDA to keep Tylenol safety label as is
Oct 21, 2025 12:04pm
RFK Jr. to link Tylenol use during pregnancy to autism: WSJ
Sep 5, 2025 3:00pm
Kenvue's strategic review stirs up CEO departure
Jul 15, 2025 11:22am
Fierce Biotech
Why 'emboldened' investors are taking the fight to biotechs
Jul 2, 2025 9:15am